Esophageal varix means enlarged veins in the esophagus that can bleed. People with esophageal varix often have liver disease and may have no symptoms until bleeding starts. Bleeding can cause vomiting blood, black stools, dizziness, and chest discomfort, and it can be life-threatening without urgent care. Treatment focuses on preventing and stopping bleeding, using medicines, endoscopic banding, and sometimes shunts or surgery. Many living with esophageal varix need ongoing care and monitoring, and avoiding alcohol and managing liver health are important.
Overview
Esophageal varixSymptoms
Esophageal varix often causes no symptoms until it bleeds. Bleeding can bring sudden vomiting of blood, black or tarry stools, dizziness or fainting, and signs of shock like rapid heartbeat and low blood pressure; this is a medical emergency.
Outlook and prognosis
Many people with esophageal varix live well with careful monitoring, medicines to lower vein pressure, and endoscopic treatments that prevent bleeding. When bleeding happens, rapid hospital care and follow-up greatly improve survival and reduce repeat events. Long-term outlook depends on liver health, alcohol use, and managing complications.
Causes and risk factors
Esophageal varix usually results from portal hypertension due to cirrhosis. Risk factors for esophageal varix include alcohol use, viral hepatitis, fatty liver, schistosomiasis, portal vein thrombosis, and inherited disorders such as hemochromatosis, Wilson disease, or alpha‑1 antitrypsin deficiency.
Genetic influences
Genetics plays little direct role in esophageal varix. It usually results from portal hypertension due to liver disease, most often from non-inherited causes. Rarely, inherited conditions that lead to liver scarring or portal vein problems can increase risk.
Diagnosis
Doctors suspect esophageal varix in people with liver disease or bleeding, then confirm it with upper endoscopy. For diagnosis of esophageal varix, blood tests and imaging assess portal hypertension and guide urgency.
Treatment and drugs
Treatment for esophageal varix focuses on preventing bleeding and managing portal hypertension. Care often includes beta‑blockers, endoscopic banding, and, when needed, procedures like TIPS; antibiotics and octreotide may be used during bleeds. Ongoing follow‑up, nutrition, and liver care are essential.
Symptoms
Esophageal varix often causes no symptoms until a bleed starts, which can be sudden and severe. Early symptoms of esophageal varix are often absent; when bleeding begins, people may vomit blood, pass black stools, feel lightheaded, or faint. Any sign of bleeding from the esophagus or stomach is an emergency.
Esophageal varix often causes no warning symptoms. Many people feel completely well until a sudden bleed starts.
Bright red blood or coffee-ground-like vomit can appear without warning. This points to bleeding in the esophagus and needs emergency care.
Tarry, black, or very dark stools with a strong odor suggest digested blood. This can follow or occur without vomiting and should be assessed urgently.
Rapid blood loss can lead to lightheadedness, weakness, or fainting. You may feel shaky or confused as blood pressure drops.
How people usually first notice Esophageal varix?
Esophageal varices rarely cause symptoms until a vein bleeds, so the first signs are often sudden: vomiting blood, black or tarry stools, lightheadedness, or fainting from blood loss. Some people notice milder clues beforehand, like a swollen belly from fluid (ascites), yellowing of the skin or eyes, easy bruising, or fatigue—features that suggest advanced liver disease, which is the usual cause of varices. If bleeding starts, it’s a medical emergency, and seeking urgent care can be lifesaving.
Types of Esophageal varix
Esophageal varix means swollen veins in the esophagus that can bleed, sometimes suddenly, and often without pain at first. The main “types of esophageal varix” people hear about are based on vein size and whether they’re bleeding or not, because those differences change symptoms and urgency. People may notice different sets of symptoms depending on their situation.
Small varices
These are early, smaller swollen veins that usually cause no symptoms. They are often found on routine endoscopy in people with liver disease.
Medium varices
These veins are larger and more likely to bleed in the future. You may still feel fine day to day, but doctors watch them closely and may recommend preventive treatment.
Large varices
These are the biggest veins and carry the highest risk of bleeding. People may have no warning signs, or they might notice subtle signs like fatigue or lightheadedness if slow bleeding occurs.
Non-bleeding varices
Varices are present but not actively bleeding. Many feel normal, and signs only show up on endoscopy or blood tests.
Acute bleeding varices
This is an emergency with vomiting blood or passing black, tarry stools. Some feel dizzy or faint due to blood loss and need urgent hospital care.
Recurrent bleeding
Bleeding stops but returns later, sometimes after weeks or months. The symptoms mirror an acute bleed, and risk factors like large size or high pressure raise the chance of it happening again.
What genetics can tell you about symptoms
Certain inherited bleeding disorders, like hemophilia or von Willebrand disease, can make esophageal varices more likely to bleed, causing vomiting blood, black stools, dizziness, or fainting. Rare genetic liver diseases—such as Wilson disease or alpha‑1 antitrypsin deficiency—can scar the liver, raising portal pressure and leading to varices that may cause chest discomfort or trouble swallowing.
Causes and risk factors
The main cause of esophageal varix is high pressure in the portal vein from liver scarring.
This pressure often builds quietly with no early symptoms of esophageal varix.
Cirrhosis can result from heavy alcohol use and from chronic hepatitis B or C.
Fatty liver disease tied to obesity or diabetes, inherited liver conditions, and portal vein clots can also raise risk.
Genes set the stage, but environment and lifestyle often decide how the story unfolds.
Environmental and biological risk factors
Esophageal varix happens when high pressure in the veins that drain the liver forces veins in the esophagus to enlarge and weaken. Many people don’t notice early symptoms of Esophageal varix because these swollen veins typically stay silent until they bleed. Awareness of both biological and environmental influences helps you feel prepared. Below are the main body-based and exposure-based risks that can raise the chance of developing esophageal varices.
Persistently high pressure in the portal vein forces nearby esophageal veins to enlarge. The higher the pressure, the greater the risk of esophageal varices and bleeding.
Advanced scarring stiffens the liver and slows blood flow. This back-pressure raises portal pressure and strongly increases the chance of esophageal varices.
Long-standing hepatitis B or C infection can injure the liver and lead to cirrhosis. Over time this can cause portal hypertension and esophageal varices.
Contact with parasite‑infested freshwater in some regions can scar the portal vein system. This can produce portal hypertension and esophageal varices even without classic cirrhosis.
Genetic risk factors
Esophageal varix often develops when high pressure builds in the portal vein, most commonly after liver damage or blocked liver blood flow. Some risk factors are inherited through our genes. Inherited liver and blood conditions can lead to scarring, bile flow problems, or clots that raise this pressure and increase the chance of varices. The genetic risk factors for Esophageal varix range from iron or copper overload disorders to clotting tendencies that narrow liver veins.
Hereditary hemochromatosis: HFE gene changes can cause iron to build up in the liver over years. This iron overload may lead to cirrhosis and portal hypertension, raising the risk of Esophageal varix.
Wilson disease: An inherited ATP7B change lets copper accumulate in the liver and other organs. Chronic copper buildup can scar the liver and increase portal pressure, which can result in Esophageal varix.
Alpha-1 antitrypsin deficiency: Certain SERPINA1 variants can damage the liver in infancy or adulthood. Advanced liver injury from this condition may progress to cirrhosis and varices.
Congenital hepatic fibrosis: This inherited disorder (often linked to PKHD1) causes scarring around the small bile ducts and early portal hypertension. Children and young adults with it often develop enlarged spleens and varices.
Cystic fibrosis liver disease: CFTR gene changes can thicken bile and block small ducts in the liver. Over time, this can cause cirrhosis and portal hypertension, increasing the chance of Esophageal varix.
Inherited thrombophilias: Variants such as Factor V Leiden or the prothrombin G20210A change raise the risk of clots in the portal or hepatic veins. These clots can trigger portal hypertension (including Budd–Chiari or portal vein thrombosis), a pathway to varices.
PFIC disorders: Progressive familial intrahepatic cholestasis, caused by changes in genes like ATP8B1 or ABCB11, impairs bile flow from early life. Long-standing cholestasis can lead to cirrhosis, portal hypertension, and varices.
Hereditary hemorrhagic telangiectasia: Inherited changes in blood-vessel genes (such as ENG or ACVRL1) can create abnormal liver vessels and high blood flow. When the liver circulation is affected, portal hypertension may develop and varices can follow.
Glycogen storage diseases: Some inherited glycogen storage conditions (for example type IV) cause progressive liver scarring. As cirrhosis advances, portal hypertension can arise, increasing variceal risk.
Lifestyle risk factors
Lifestyle choices can influence the development of portal hypertension and the chance that esophageal varices enlarge or bleed. Below are lifestyle risk factors for Esophageal varix and how lifestyle affects Esophageal varix day to day. Diet, alcohol, physical activity, and certain behaviors can shift portal pressures and bleeding risk.
Chronic heavy drinking drives liver scarring and portal hypertension, increasing varix formation. Binge episodes can trigger vomiting and mucosal injury that raise bleeding risk.
Excess sodium promotes fluid retention and ascites, which can elevate portal pressure on varices. Lower-salt eating may reduce wall tension and bleeding risk.
Weight gain and sedentary habits increase the risk of fatty liver that can progress to cirrhosis and varices. Regular activity and weight loss can lower liver fat and portal pressures.
High-fructose beverages and ultra-processed foods worsen fatty liver, advancing portal hypertension over time. Replacing them with whole foods may improve liver enzymes and steatosis.
Risk prevention
You can’t always prevent an esophageal varix because it usually develops from long-standing liver strain, but you can lower the chances and reduce bleeding risk. Caring for your liver, getting checked regularly, and using proven treatments can make a real difference. Prevention is about lowering risk, not eliminating it completely. There are usually no early symptoms of esophageal varix, so screening matters if you live with liver disease.
Address the cause early—stop alcohol, treat hepatitis, and manage fatty liver with steady weight loss and activity. This can slow scarring and high pressure in the vein to the liver, lowering the chance that esophageal varices form.
Alcohol strains and scars the liver over time. Stopping alcohol can reduce the pressure that feeds esophageal varices and lowers bleeding risk.
Get vaccinated for hepatitis A and B if you’re not immune, and get tested and treated for hepatitis C. Preventing or curing viral hepatitis helps protect the liver and reduces the risk of an esophageal varix.
If you have cirrhosis, schedule screening upper endoscopy as advised. Finding esophageal varices early allows treatment such as banding to prevent bleeding.
Transmission
Esophageal varix isn’t contagious and can’t be passed from person to person through touch, sex, coughing, food, or water. It develops because of very high pressure in the vein system that carries blood from the gut to the liver (portal hypertension), most often from liver scarring. Esophageal varix is also not inherited on its own; while some liver diseases have infectious causes (like hepatitis B or C) or, less often, genetic causes, those are the underlying conditions—not the varix—being transmitted. In short, there is no mode of transmission for esophageal varix, and it does not spread within families or communities.
When to test your genes
Esophageal varices are usually from liver disease, so genetic testing isn’t routine for diagnosis. Consider testing if you have a strong family history of liver disease with known inherited causes (like hemochromatosis) or unexplained cirrhosis at a young age. Test results can guide screening frequency, alcohol limits, and medication choices.
Diagnosis
Esophageal varix is usually picked up when bleeding symptoms prompt urgent care or during routine screening in people with liver scarring. You might notice vomiting blood, black tarry stools, or lightheadedness after standing—signals that need immediate attention. Doctors usually begin with your symptoms and liver history, then decide which tests are needed. If you’re wondering how esophageal varix is diagnosed, it often centers on looking directly at the esophagus and checking for signs of high pressure in the portal vein system.
Clinicians ask about vomiting blood, black stools, dizziness, and fatigue. They also review liver conditions like cirrhosis, past hepatitis, alcohol use, and prior bleeding.
The exam looks for jaundice, abdominal swelling, and an enlarged spleen—features that suggest portal hypertension. Blood tests check hemoglobin, platelets, liver function, and clotting to gauge bleeding severity and overall risk.
A thin camera is used to see the esophagus directly and confirm varices, which makes the diagnosis of esophageal varix clear. The size and surface features are graded, and treatment like banding can often be done during the same procedure.
Ultrasound with Doppler, CT, or MRI can show signs of portal hypertension and collateral veins. These studies help identify the cause and map the extent of vein changes.
Stages of Esophageal varix
Esophageal varices are graded mainly by what’s seen during an upper endoscopy—how big the veins are and whether there are warning signs for bleeding. These grades reflect the risk of a future bleed and help guide monitoring and prevention. Many people feel reassured knowing what their tests can—and can’t—show.
Small varices
Veins are enlarged but thin and usually don’t cause symptoms. Often no early symptoms of esophageal varices appear at this stage.
Medium varices
Veins are more prominent and may look squiggly or bulging. The chance of bleeding is higher than with small varices.
Large varices
Veins are wide and tense, with a clear risk of bleeding. Preventive treatment is often advised to lower that risk.
High-risk signs
Thin red streaks or spots on varices signal a higher chance of bleeding. Doctors may recommend urgent preventive steps like banding or medicines.
Active bleeding
People may vomit blood or pass black, tarry stools, and feel lightheaded. This is an emergency and needs immediate care to stop the bleed and stabilize you.
After bleeding
Once bleeding is controlled, care focuses on preventing another bleed and treating the liver condition that caused the varices. Follow-up endoscopy is scheduled to check healing and plan ongoing protection.
Outlook and prognosis
Bleeding risk is the biggest concern with esophageal varix, and the outlook depends largely on liver health, the size of the veins, and whether bleeding has happened before. The first bleed can be life‑threatening; in-hospital survival has improved with modern care, but rebleeding is common without prevention. Early care can make a real difference, especially when people receive banding, beta‑blockers, and careful follow‑up to lower pressure in the portal vein.
Looking at the long-term picture can be helpful. After a bleed, the chance of another bleed is highest in the first weeks to months, which is why doctors often combine endoscopic banding with medicines. For many living with esophageal varix linked to cirrhosis, long‑term outlook is shaped more by the underlying liver disease than by the veins themselves. If liver function is poor or there’s fluid buildup, jaundice, or confusion, overall survival is shorter; if liver function is preserved and prevention is in place, people can live many years.
People often ask about early symptoms of esophageal varix, but most varices stay silent until they bleed, showing up as vomiting blood or black stools. Preventive screening in those with cirrhosis aims to catch varices before a crisis, and some may be candidates for a shunt procedure (TIPS) or, in advanced cases, liver transplant to reduce bleeding risk. With ongoing care, many people maintain stability and avoid major bleeding episodes for long stretches. Talk with your doctor about what your personal outlook might look like, including your bleeding risk, liver scores, and the plan to lower that risk over time.
Long-term effects
Esophageal varix can bring risks that extend well beyond a first bleeding episode. Long-term effects vary widely, depending most on the underlying liver disease and pressure in the portal vein system. Many people have no early symptoms of esophageal varix, so the long-term picture is often shaped by if and how bleeding occurs. Over time, outlook tends to follow the health of the liver and how often bleeding or related complications happen.
Once bleeding has happened, the chance of another episode stays higher than average over time. Rebleeds can be sudden and severe, and they may lead to emergency care.
Slow or repeated blood loss can lead to low red blood cells. This often shows up as tiredness, shortness of breath, and looking pale.
Liver-related toxin buildup can trigger confusion, poor concentration, or sleep–wake flips. These episodes may come and go and can range from mild to more serious.
Ongoing portal pressure can lead to fluid in the belly (ascites) and leg swelling. This can make breathing, eating, and moving around less comfortable.
How is it to live with Esophageal varix?
Living with esophageal varices can feel unpredictable, because you may have no symptoms day to day yet still carry the risk of sudden bleeding. Many people build new routines—taking medicines as prescribed, avoiding alcohol, keeping up with endoscopy appointments, and learning the warning signs of bleeding—so they can stay active while lowering risk. Loved ones often get involved too, helping with transportation, meal planning, and having an action plan for emergencies, which can ease worry for everyone. With a clear care plan, realistic limits on heavy lifting or straining, and support from a liver or GI team, many find a steady rhythm that keeps life safer and more manageable.
Treatment and drugs
Esophageal varix treatment focuses on lowering the risk of bleeding, stopping active bleeds, and preventing future episodes. During an active bleed, doctors act quickly with IV fluids, blood transfusion if needed, medicines that reduce blood flow to the gut (such as octreotide or terlipressin), and an urgent endoscopy to place rubber bands around the veins (band ligation) or, less often, glue or clips. After bleeding is controlled, most people start a nonselective beta blocker (like propranolol or nadolol) and return for repeat banding sessions until the varices shrink, since this combination lowers the chance of another bleed. If bleeding keeps happening despite these steps, a radiology procedure called TIPS creates a new pathway through the liver to reduce pressure in the veins; rarely, surgery or liver transplant is considered. Alongside medical treatment, lifestyle choices play a role, including avoiding alcohol, managing liver disease, staying up to date with vaccinations, and discussing medicines that may increase bleeding risk, such as NSAIDs.
Non-drug treatment
Non-drug care for esophageal varix focuses on preventing a first bleed, stopping active bleeding quickly, and lowering pressure in the veins to reduce future risk. Alongside medicines, non-drug therapies can play a central role in both emergency care and long-term prevention. These options range from endoscopic procedures done through a scope to image-guided shunts that reroute blood flow. Lifestyle steps and regular check-ins help support healing and lower the chance of another bleed.
A doctor places tiny rubber bands around enlarged veins to seal them off. This is often the first-choice procedure to stop active bleeding and to prevent future bleeding.
A solution is injected into or near the vein through a scope to make it scar and close. It may be used when banding is not possible or if bleeding keeps going.
A radiology-guided shunt connects two veins inside the liver to lower portal pressure. This can control bleeding that keeps returning despite endoscopic treatment.
A removable, covered metal stent can press on bleeding veins from the inside. It is usually a short-term bridge when banding fails or bleeding is severe.
Your genes may have an impact on how drugs work for you
Medications for esophageal varices—like nonselective beta-blockers to lower portal pressure—can work differently depending on your genes, which influence drug absorption, breakdown, and target sensitivity. Pharmacogenetic differences may affect dose needs, side effects, and overall protection against bleeding.
Pharmacological treatments
Medicines for Esophageal varix aim to prevent the first bleed, stop active bleeding, and lower the chance of bleeding again. Because early symptoms of Esophageal varix are uncommon, preventive drugs are often started after an endoscopy shows medium or large varices. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy). Your team will match each drug to your situation, liver health, and blood pressure.
Propranolol, nadolol, or carvedilol lower pressure in the portal vein to prevent a first bleed or rebleeding in Esophageal varix. Dosing may be increased or lowered gradually to find the safest, most effective dose.
Carvedilol can lower portal pressure a bit more than traditional beta-blockers. It may drop blood pressure, so doctors start low and monitor for dizziness.
Octreotide given by IV helps constrict blood vessels in the gut and quickly slows active bleeding from Esophageal varix. It is usually continued for 2–5 days while other treatments, like banding, are arranged.
Terlipressin is an IV medicine used in many countries to control acute variceal bleeding. It can reduce the risk of death but may cause chest pain or reduced blood flow to the hands or gut.
Genetic influences
Genetics tends to influence the development of an esophageal varix indirectly, by making some people more likely to develop liver disease or blood-flow problems that raise pressure in the veins feeding the esophagus. Inherited liver conditions—such as hereditary hemochromatosis (iron overload), Wilson disease (copper buildup), or alpha‑1 antitrypsin deficiency—can lead to scarring of the liver over time and increase the chance of varices. Some people also inherit a tendency to form blood clots, like factor V Leiden or a prothrombin gene change, which can block the portal vein and create the high pressures that cause varices. Family patterns of autoimmune liver disease or congenital liver scarring can contribute as well, though these causes are less common. Having a genetic risk is not the same as having the disease itself. If varices appear in someone without typical triggers (like heavy alcohol use or viral hepatitis), doctors may review family history and, when needed, order targeted tests for specific inherited liver or clotting conditions.
Is Esophageal varix genetic?
Genetics plays little direct role in esophageal varix. It usually results from portal hypertension due to liver disease, most often from non-inherited causes. Rarely, inherited conditions that lead to liver scarring or portal vein problems can increase risk.
Pharmacogenetics—how genetics influence drug effects
Treatment of esophageal varix relies on urgent procedures and specific medicines, and your genes can sometimes affect how those medicines work. Genes can influence how quickly you clear certain nonselective beta blockers, such as propranolol or carvedilol, which are used to lower portal pressure after bleeding is controlled. People who process these drugs slowly may feel dizzy or have very low heart rates on standard doses, while very fast processors may need a different dose or a different beta blocker; a common liver enzyme gene (often called CYP2D6) is one reason for these differences. PPIs, occasionally used around endoscopic banding to help heal the esophagus, are affected by another enzyme gene (CYP2C19), so some people get higher or lower levels than expected. Genetic testing can sometimes identify how your body handles these medicines, but it isn’t routine for esophageal varix care and doctors still base choices mainly on your heart rate, blood pressure, and liver and kidney function. Differences in response also come from age, other drugs, and the severity of liver disease. As research grows, pharmacogenetics in esophageal varix treatment may guide safer dosing for certain drugs, while procedures like banding and shunts remain the mainstay.
Interactions with other conditions
Flare-ups of infections, bouts of vomiting, or straining with constipation can raise pressure in the veins and make bleeding more likely if Esophageal varix is present. Doctors call it a “comorbidity” when two conditions occur together. Esophageal varix most often appears alongside cirrhosis driven by hepatitis B or C, alcohol-related liver disease, or metabolic fatty liver disease; portal vein thrombosis can lead to a similar pressure buildup. Low platelets and clotting problems that come with advanced liver disease—and the platelet dysfunction seen in chronic kidney disease—can further increase the risk of a serious bleed. Other health issues can shape treatment choices, too; for example, asthma or severe peripheral artery disease may limit the use of nonselective beta-blockers that help prevent variceal bleeding. Because early symptoms of Esophageal varix are often absent until bleeding starts (vomiting blood or black, tarry stools), it’s worth planning with your care team how your other conditions might affect screening, medicines, and follow-up.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden bouts of vomiting blood after a heavy meal or night of drinking, followed by weakness and dizziness. Families and communities once noticed patterns in those with long‑standing liver trouble who later developed these frightening bleeds. Before modern scans, many lived with indigestion, swelling, or jaundice for years without knowing that enlarged veins in the swallowing tube—the medical term is esophageal varix—were quietly forming.
First described in the medical literature as dilated veins linked to “portal” pressure from liver disease, early reports came from autopsies and emergency surgeries. Doctors could see rope‑like veins just above the stomach but had few safe ways to treat them. In the mid‑20th century, rigid scopes and X‑rays offered the first real-time views, though procedures were risky. As fiber‑optic endoscopy arrived in the 1960s and 1970s, clinicians could finally see small, medium, and large varices, photograph them, and tie what patients felt—heartburn, black stools, lightheadedness—to what the doctor observed.
From early theories to modern research, the story of esophageal varix has been shaped by understanding liver disease and blood flow. When scientists mapped the “portal” circulation, they recognized why scarring of the liver raises pressure and pushes blood into backup channels in the esophagus. This insight reframed bleeding not as an isolated event but as a consequence of the whole system struggling to reroute blood. It also explained why some people with cirrhosis never bleed while others do: vein size, wall tension, and surface marks seen on endoscopy signal different levels of risk.
Therapies evolved alongside these discoveries. Decades ago, emergency care relied on packing the esophagus with balloon tubes to compress the veins—effective but uncomfortable and temporary. Later, band ligation and sclerotherapy through flexible scopes allowed doctors to pinch or seal the varices directly, dramatically reducing rebleeding. Medicines that gently lower portal pressure, like nonselective beta‑blockers, shifted care from reaction to prevention. For severe cases, the development of shunt procedures, including TIPS (a stent that reroutes blood within the liver), offered a bridge while people pursued transplant evaluation.
In recent decades, knowledge has built on a long tradition of observation. Screening endoscopy for those with cirrhosis, careful alcohol and viral hepatitis treatment, and better nutrition have all changed the outlook. What was once a sudden, often fatal emergency is now a condition many live with under close follow‑up, combining lifestyle changes, medicines, and timely procedures. Looking back helps explain why today’s care focuses not just on stopping a bleed, but on preventing the next one and treating the liver disease at its source.